The COVID-19 vaccine is available to all people 12 years and older who live or work in Washington state. Bartell’s is currently offering appointments for 1st and 2nd doses of the Pfizer COVID-19 and Moderna COVID-19 vaccines, as well as Pfizer boosters for ages 65+, Long Term Care Residents and eligible individuals ages 18-64 with underlying medical conditions or occupational or institutional risk. Learn more.
MAKE AN APPOINTMENT FOR PFIZERVaccine available for ages 12 and up
Select Bartell pharmacies have limited appointments for the 1st dose of the COVID-19 vaccine at this time. Please select the Pfizer vaccine for children ages 12 and up.
MAKE AN APPOINTMENT FOR MODERNAVaccine available for ages 18 and up
Select Bartell pharmacies have limited appointments for the 1st dose of the COVID-19 vaccine at this time. Moderna is only available for patients ages 18 and up.
*You will not be turned away if you do not have a photo ID.
*Medical conditions are defined as: cancer, cerebrovascular disease, chronic kidney disease, COPD, diabetes, heart conditions, obesity, pregnancy or recent pregnancy, smoking (current and former).
Customers must have received the Pfizer COVID-19 vaccine. This update does not apply to those who received the Moderna or Johnson & Johnson/Janssen COVID-19 vaccine.
Additional doses have been authorized for:
Moderately to severely immunocompromised individuals who received their 2nd dose of the Moderna or Pfizer COVID-19 vaccine at least 28 ago. Specifically, authorized individuals include the following:
Customers must have received either the Pfizer or Moderna COVID-19 vaccine. This update does not apply to those who received the Johnson & Johnson/Janssen COVID-19 vaccine.
Pfizer boosters can be administered to eligible individuals 6 months after the 2nd dose of a Pfizer vaccine.
Boosters on the other hand, are meant to address decreasing or waning vaccine effectiveness over time for people who had an expected immune response. Most studies continue to show that the COVID-19 vaccines are effective against COVID-19, particularly when it comes to severe infection and hospitalization.
No, for immunocompromised additional dose: At this time, pregnant individuals are not considered part of the specified immunocompromised conditions.